Connection
Nadine Mikhaeel-Kamel to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Nadine Mikhaeel-Kamel has written about Dose-Response Relationship, Drug.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.007 |
|
|
|
-
Kelly K, Mikhaeel-Kamel N, Pan Z, Murphy J, Prindiville S, Bunn PA. A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer. Clin Cancer Res. 2000 Sep; 6(9):3474-9.
Score: 0.007